| Authors: |
Jamieson PJ; Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Shen X; Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA., Abu-Shmais AA; Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Wasdin PT; Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Program in Chemical and Physical Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Janowska K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA., Edwards RJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA., Scapellato G; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA., Bukenya M; Department of Integrative Immunobiology, Duke University School of Medicine, Durham, North Carolina, USA.; Center for Human Systems Immunology, Duke University School of Medicine, Durham, North Carolina, USA., Bass LE; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Richardson SI; South African Medical Research Council Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa., Manamela NP; South African Medical Research Council Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa., Liu S; Worcester HIV Vaccine, Worcester, Massachusetts, USA., Barr M; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA., Adams L; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts, USA., Paola Velez-Castro C; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts, USA., McCarthy C; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts, USA., Alexander CA; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts, USA., Gillespie RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA, Bethesda, Maryland, USA., Mimms J; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Suryadevara N; Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Sornberger TA; Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Zost SJ; Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Parks R; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA., Flaherty S; Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA., Janke AK; Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Howard BN; Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Suresh YP; Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Program in Chemical and Physical Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Ruprecht RM; Texas Biomedical Research Institute and Southwest National Primate Research Center, San Antonio, Texas, USA., Crowe JE Jr; Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Program in Chemical and Physical Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Carnahan RH; Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Bailey JR; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Kanekiyo M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA, Bethesda, Maryland, USA., Lingwood D; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts, USA., Haynes BF; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Integrative Immunology, Duke University School of Medicine, Durham, North Carolina, USA., Moore PL; South African Medical Research Council Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa., Bonami RH; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Department of Medicine, Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Tomaras GD; Department of Integrative Immunobiology, Duke University School of Medicine, Durham, North Carolina, USA.; Center for Human Systems Immunology, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA., Archarya P; Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Biochemistry, Duke University School of Medicine, Durham, North Carolina, USA., Montefiori DC; Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA., Kalams SA; Infectious Diseases Unit, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Department of Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Lu S; Worcester HIV Vaccine, Worcester, Massachusetts, USA., Georgiev IS; Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Program in Chemical and Physical Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Department of Computer Science, Vanderbilt University, Nashville, Tennessee, USA.; Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, USA.; Center for Computational Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. |
